Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
COHEN & COMPANY INC.	COHN	Nyse	26,714	9.43 USD	Stock
COHEN & STEERS, INC.	CNS	Nyse +3 Other	193,398	73.22 USD	Stock
COHEN & STEERS, INC.	FG9	Deutsche Boerse AG	-	67 EUR
COHEN & STEERS, INC.	FG9	BOERSE MUENCHEN	-	67.5 EUR
COHEN & STEERS, INC.	FG9	Börse Stuttgart	-	66.5 EUR
COHEN & STEERS INFRASTRUCTURE FUND, INC	UTF	Nyse	188,267	23.56 USD	Stock
COHEN DEVELOPMENT GAS & OIL LTD.	CDEV	TEL AVIV STOCK EXCHANGE	2,678	10,620 ILa	Stock
COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC.	FOF	Nyse	59,356	11.83 USD	Stock
COHEN & STEERS TOTAL RETURN REALTY FUND, INC.	RFI	Nyse	57,414	11.57 USD	Stock
COHEN & STEERS QUALITY INCOME REALTY FUND, INC.	RQI	Nyse	313,089	11.62 USD	Stock
COHEN & STEERS SELECT PREFERRED AND INCOME FUND, INC.	PSF	Nyse	32,915	19.42 USD	Stock
COHEN & STEERS REIT AND PREFERRED INCOME FUND, INC.	RNP	Nyse	85,307	20.6 USD	Stock
COHEN & STEERS REAL ESTATE OPPORTUNITIES & INCOME FUND	RLTY	Nyse	63,478	13.81 USD	Stock

See all

News (305)

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences	05-09	BU
FBG Enterprises Opco, LLC completed the acquisition of PointsBet USA Inc. from PointsBet Holdings Limited.	04-02	CI
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	04-01	AQ
Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia	03-11	AQ
Blackstone Management Partners L.L.C. completed the acquisition of Rover Group, Inc. from Madrona Venture Group, LLC, Foundry Ventures LLC, Menlo Ventures Management, L.P., True Wind Capital Management, L.P., Nebula Caravel Holdings, LLC and others.	02-26	CI
Transcript : Gartner, Inc., Q4 2023 Earnings Call, Feb 06, 2024	02-06
Air Water Ventures Ltd cancelled the acquisition of Athena Technology Acquisition Corp. II from a group of shareholders in a reverse merger transaction.	12-12	CI
INSTACART ADDS PEACOCK AS FIRST-EVER STREAMING PARTNER	11-29	PR
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update	11-14	AQ
Tonix Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Highlights	11-09	AQ
Gartner : Earnings Document	11-06	PU
Transcript : Gartner, Inc., Q3 2023 Earnings Call, Nov 03, 2023	11-03
Starton Therapeutics, Inc. cancelled the acquisition of Healthwell Acquisition Corp. I from a group of shareholders in a reverse merger transaction.	11-02	CI
FL Entertainment N : Banijay UK acquires leading scripted producer The Forge	11-02	PU
DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)	20/10/23	AQ
DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth	19/10/23	AQ
DMK Pharmaceuticals Corporation Announces CFO Changes	19/10/23	CI
DMK Pharmaceuticals Corporation Announces Executive Changes	19/10/23	CI
Zuffa, LLC completed the acquisition of World Wrestling Entertainment, Inc. from Vincent McMahon.	11/09/23	CI
FBG Enterprises Opco, LLC completed the acquisition of PointsBet USA Inc. from PointsBet Holdings Limited for approximately $230 million.	30/08/23	CI
Transcript : RumbleON, Inc., Q2 2023 Earnings Call, Aug 09, 2023	09/08/23
Transcript : Gartner, Inc., Q2 2023 Earnings Call, Aug 01, 2023	01/08/23
CASI Pharmaceuticals Acquires Global Intellectual Property Rights to Cleave Therapeutics' VCP/P97 Inhibitor CB-5339	20/07/23	PR
FBG Enterprises Opco, LLC entered into a stock and equity sale agreement to acquire PointsBet USA Inc. from PointsBet Holdings Limited for $150 million.	13/05/23	CI
Transcript : Paramount Global, Q1 2023 Earnings Call, May 04, 2023	04/05/23
Transcript : Gartner, Inc., Q1 2023 Earnings Call, May 02, 2023	02/05/23
Stryker Corporation completed the acquisition of Cerus Endovascular Ltd for approximately $530 million.	01/05/23	CI
Air Water Ventures Ltd entered into a definitive agreement to acquire Athena Technology Acquisition Corp. II from a group of shareholders in a reverse merger transaction for approximately $300 million.	19/04/23	CI
Chiesi Farmaceutici S.p.A. completed the acquisition of Amryt Pharma plc from Athyrium Capital Management, LP, Highbridge Capital Management, LLC, Joe Wiley, Rory Nealon, Ray Stafford and others.	11/04/23	CI
Zuffa, LLC entered into an agreement to acquire World Wrestling Entertainment, Inc. from Vincent McMahon.	02/04/23	CI
ReFrame and IMDbPro Announce 2022 ReFrame Stamp Film Recipients	01/03/23	BU
Gartner : FQ4 2022 Earnings Call Transcripts	09/02/23	PU
Bed Bath & Beyond plunges after last-ditch effort to avoid bankruptcy	07/02/23	RE
Transcript : Gartner, Inc., Q4 2022 Earnings Call, Feb 07, 2023	07/02/23
Chiesi Farmaceutici S.p.A. entered into a definitive agreement to acquire Amryt Pharma plc from Athyrium Capital Management, LP, Highbridge Capital Management, LLC, Joe Wiley, Rory Nealon, Ray Stafford and others for $1.1 billion.	07/01/23	CI
Transcript : SS&C Technologies Holdings, Inc. Presents at Credit Suisse 26th Annual Technology Conference, Nov-29-2022 10:15 AM	29/11/22
Transcript : Gartner, Inc., Q3 2022 Earnings Call, Nov 01, 2022	01/11/22
Stryker Corporation signed an agreement to acquire Cerus Endovascular Ltd.	30/10/22	CI
L'Oreal signs an agreement to acquire Skinbetter Science, a physician-dispensed American skincare brand	26/09/22	AQ
L'Oreal : L’Oréal signs an agreement to acquire Skinbetter Science, a physician-dispensed American skincare brand	23/09/22	PU
L'Oréal: News Release: "L’Oréal signs an agreement to acquire Skinbetter Science, a physician-dispensed American skincare brand"	23/09/22	GL
PRECIPIO, INC. : Other Events (form 8-K)	19/09/22	AQ
CPI Property S A : Press release - New York Litigation Dismissed by the U.S. Court of Appeals	01/09/22	PU
CPI PROPERTY GROUP – New York Litigation Dismissed by the U.S. Court of Appeals	01/09/22	EQ
Transcript : Dolphin Entertainment, Inc., Q2 2022 Earnings Call, Aug 15, 2022	15/08/22

1234NextSee all

Companies (11)

COHEN & STEERS, INC. 3 695 M $

Cohen & Steers, Inc. is a holding company, which is engaged in global investment management. The Company is specialized in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equitie ...

COHEN & STEERS REAL ESTATE OPPORTUNITIES & INCOME FUND 211 M $

Cohen & Steers Real Estate Opportunities & Income Fund (the Fund) is a non-diversified, closed-end management investment company. The Fundâs primary investment objective is high current income. The Fundâs secondary investment objective is capital appr ...

COHEN & STEERS QUALITY INCOME REALTY FUND, INC. 1 556 M $

Cohen & Steers Quality Income Realty Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's primary investment objective is high current income through investment in real estate securities. The Fund's secondary invest ...

COHEN & STEERS REIT AND PREFERRED INCOME FUND, INC. 976 M $

Cohen & Steers REIT and Preferred and Income Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is high current income. The Fund's secondary investment objective is capital appreciation. The F ...

COHEN & STEERS LIMITED DURATION PREFERRED AND INCOME FUND, INC. 573 M $

Cohen & Steers Limited Duration Preferred & Income Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fundâs primary investment objective is high current income. The Fundâs secondary investment objective is capital a ...

COHEN & STEERS INFRASTRUCTURE FUND, INC 2 268 M $

Cohen & Steers Infrastructure Fund, Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is total return, with an emphasis on income through investment in securities issued by infrastructure companies. U ...

COHEN & STEERS SELECT PREFERRED AND INCOME FUND, INC. 233 M $

Cohen & Steers Select Preferred and Income Fund, Inc. (the Fund) is a closed-end management investment company. The Fundâs primary investment objective is high current income. The Fundâs secondary investment objective is capital appreciation. It inves ...

COHEN & COMPANY INC. 15 M $

Cohen & Company Inc. is a financial services company. The Companyâs segments include Capital Markets, Asset Management, and Principal Investing. Capital Markets consists of fixed income sales, trading, and gestation repo financing as well as new issue p ...

COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. 323 M $

Cohen & Steers Closed-End Opportunity Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to achieve total return, consisting of high current income and potential capital appreciation. The F ...

COHEN & STEERS TOTAL RETURN REALTY FUND, INC. 306 M $

Cohen & Steers Total Return Realty Fund, Inc. is a diversified, closed-end management investment company. The Fund's investment objective is to achieve a high total return through investment in real estate securities. The Fund seeks both current income an ...

12Next

Insiders

Seth Cohen

Seth A.
Cohen is currently the Chief Financial Officer at DMK Pharmaceuticals Corp.
He previously worked as the Director of Pensions & Public Finance at the City of New York from 1998 to 2000, and as the CFO, CAO, Treasurer & Senior Vice President at NewtekOne, Inc. from 2000 to 2011.
Cohen received his undergraduate degree from Yale University and his MBA from Columbia Business School.

Seth Cohen

Seth Cohen is the founder of Cleave Therapeutics, Inc. founded in 2010.
He is currently a Professor at the University of California San Diego.
Dr. Cohen's education includes an undergraduate degree from Stanford University and a doctorate from the University of California, Berkeley.
Dr. Cohen is also the founder of Forge Therapeutics, Inc.

Seth Cohen

Seth Cohen has worked as a Director at Bocks, Inc. and as a Managing Partner at Reynolds Channel Management LP.

Seth Cohen

Mr. Seth Cohen is a Principal at AB CarVal Investors LP.
He is responsible for managing loan portfolio investments globally.
Prior to joining AB CarVal in 2009, Mr. Cohen was responsible for structured finance transaction origination, analysis and execution at Garrison Investment Group.
He was previously with Silver Point Capital where he deployed both debt and equity through a range of investments in various structured product and illiquid asset classes, including consumer receivables such as mortgages, auto finance and credit cards, rediscount lending and fixed income venture capital opportunities.
He also co-headed the financial services group within principal finance.
He was previously the CEO of Franklin Credit Management Corporation, a publicly traded specialty finance company and spent four years as the chief operating officer of MagnaCare.
Mr. Cohen received his J.D.
from NYU School of Law and his A.B.
in political science from the University of Michigan, graduating with honors and distinction.

Seth Cohen

Seth A. Cohen

Seth Cohen

Seth Cohen is currently the Director at Rainforest Alliance, Inc. He is also a Partner at Valinor Management LP and a Principal at VPCP Management LP.
Previously, he worked as a Director at dELiA*s, Inc. and as a Senior Analyst at The Blackstone Group, Inc. Mr. Cohen completed his undergraduate degree from The Wharton School of the University of Pennsylvania in 2004.

No results for this search